Caris Life Sciences, Inc. (CAI)
NASDAQ·Healthcare·Biotechnology
$25.23
-3.27%
Mkt Cap $7.13B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (13 analysts)
$26.00
Range $21.00 – $33.00
Implied Upside
+3.1%
Consensus $26.00 vs current $25.23
NASDAQ·Healthcare·Biotechnology
$25.23
-3.27%
Mkt Cap $7.13B
Buy
11
Hold
1
Sell
0
Price Target (13 analysts)
$26.00
Range $21.00 – $33.00
+3.1%
Consensus $26.00 vs current $25.23